検索新着情報News
【TargetMol】新製品(11月版)のご紹介
- 2024/12/09
- サプライヤニュース
 |
|
| New Compound | November |
 |
ZD-6888 Hydrochloride (ZD-6888 HCl) is an angiotensin II (AII) antagonist that mediates AII receptor blockade and induces a competitive inhibition of AII-mediated renin release.
Research Areas: Neurological Disease Targets: Dopamine Receptor |
|
PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction.
Research Areas: Tuberculosis Targets: Others |
 |
 |
5-OP-RU is a MAIT-activating ligand, the major antigen of MAIT cells, a mucosal adjuvant, induces efficient enrichment of mucosal-associated invariant T cells, and can be used to study Mycobacterium tuberculosis infections.
|
|
BI-4732 is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with high blood-brain barrier permeability, antitumor activity, inhibition of EGFR activation, and inhibition of T790M mutations.
Research Areas: Cancer Targets: EGFR |
 |
 |
Cianopramine (Ro 112465) is a selective 5-hydroxytryptamine uptake inhibitor and a tricyclic antidepressant used in the study of neurological disorders.
Research Areas: Neurological Disease Targets: 5-HT Receptor |
|
Leritrelvir (RAY1216) is an orally active and highly potent protease inhibitor with antiviral activity that blocks cleavage of viral precursor proteins and inhibits viral replication in SARS-CoV-2.
Research Areas: Infection Targets: SARS-CoV |
 |
 |
Valomaciclovir stearate (A-174606. 0) is a nucleoside analog with antiviral activity against varicella-zoster virus (VZV), and has been used in the study of VZV infections.
Research Areas: Infection Targets: HSV |
|
|
| Tel: 781-999-4286 Email: marketing@targetmolchemicals.email Add: 36 Washington Street, Wellesley Hills, MA 02481. |
|
* {
font-family: Verdana, Alright Sans, Calibri, Arial, Helvetica, Sans-Serif;
}
.compound_name {
font-weight: bold;
font-size: 17px;
padding: 0px 0px 2px 2px;
text-align: left
}
.compound_des {
font-size: 12px;
padding: 3px 0px 3px 0px;
}
.compound_img {
border-style: none;
padding: 2px 2px 2px 2px;
}
.learn_more {
padding: 0px 0px 2px 2px;
font-size: 14px;
font-weight: bold;
color: #D8D8E1;
text-align: right
}
a:link {
color: #4852A9;
}
a:visited {
color: #4852A9;
;
}
a:hover {
color: #4852A9
;
8;
}
a:active {
color: lightgrey
}
.menu {
background: #FFF0FC;
font-size: 13px;
font-weight: bold;
text-align: center;
padding: 20px 20px 20px 20px;
}
.blank_row {
background-color: #D8D8E1
}
.nav_item{
padding: 10px;
display: flex;
justify-content: center;
}
.nav_item> a {
width: 25%;
text-align: center;
}
/* CMS Other Editor Test */
@media only screen and (max-width: 480px){
body { margin: 0; padding: 0; }
}
@media only screen and (max-width: 480px){
table[class=container-table], .bmeheadertext, .container-table{ width: 95% !important;}
}
@media only screen and (max-width: 480px){
.header{font-size: 24px !important;}
}
@media only screen and (max-width: 480px){
.contenttitle{font-size: 20px !important;line-height: 140% !important;}
}
@media only screen and (max-width: 480px){
.contenttext{font-size: 16px !important;line-height: 140% !important;}
}
@media only screen and (max-width: 480px){
.single-col{display: block !important; width: 100% !important; float:left; clear:both;}
}
@media only screen and (max-width: 480px){
img.mobile-img-large { width: 100% !important; height:auto !important;display:block;}
}
@media only screen and (max-width: 480px){
img.bmeRSSImage{max-width:300px; height:auto !important;}
}
@media only screen and (max-width: 480px){
td[class="preheader-table"]{padding: 10px 0 !important;}
}
@media only screen and (max-width: 480px){
div[class="bmeheadertext"]{font-size: 12px !important;line-height: 140% !important;}
}
@media only screen and (max-width: 480px){
td[class="bmefootertext"], div[class="bmefootertext"]{font-size: 12px !important;padding-top: 10px;line-height: 140% !important;}
}
@media only screen and (max-width: 480px){
div[class="bmefooter"] td[width="79%"], div[class="bmefooter"] td[width="21%"]{display: block !important;width: 100%;}
}
@media only screen and (max-width: 480px){
.mobile-footer, .mobile-footer a{ font-size: 13px !important; line-height: 18px !important;}
}
@media only screen and (max-width: 480px){
.mobile-footer{ text-align: center !important;}
}
@media only screen and (max-width: 480px){
div.bmefooter, div.bmeheader{ display:block !important;}
}
@media only screen and (max-width: 480px){
table[class="share-tbl"] { padding-bottom: 15px; width: 100% !important;}
}
@media only screen and (max-width: 480px){
table[class="share-tbl"] td { display: block !important; text-align: center !important; width: 100% !important;}
}
@media only screen and (min-width: 640px){
img.bmeRSSImage{max-width:500px !important; height:auto !important;}
}
/* ---extra-- */
table[width="100%"] { width: 100%; }
table[align="center"] { margin: 0 auto; }
td[align="center"] { text-align: center; }
table[width="640"] { width: 640px; }
td { line-height: 1.3; text-align: left; }
td[align="right"] { text-align: right; }
TargetMol(ターゲットモル)社について
- 本社所在地
- アメリカ マサチューセッツ州
- URL
- https://www.targetmol.com/
TargetMolは、ボストンに本社を置く低分子およびスクリーニングライブラリのサプライヤです。ライフサイエンス試薬、阻害剤、活性剤、実験用および科学用の天然化合物を提供しています。ポートフォリオには、6,000を超える化合物/阻害剤（カタログ）と80種類を超える化合物ライブラリがあります。